Article
FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
Prostate cancer and prostatic diseases - 1 Mar 2010
Ho C K M, Anwar S, Nanda J, Habib F K
Abstract excerpt
Fibroblast growth factor receptor 4 (FGFR4), a member of the fibroblast growth receptor family, was recently reported to be more abundantly expressed in malignant than benign prostate cells. A single nucleotide polymorphism at position 388 of the FGFR4 amino-acid sequence results in the substitut...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
